JP2011515399A5 - - Google Patents

Download PDF

Info

Publication number
JP2011515399A5
JP2011515399A5 JP2011500808A JP2011500808A JP2011515399A5 JP 2011515399 A5 JP2011515399 A5 JP 2011515399A5 JP 2011500808 A JP2011500808 A JP 2011500808A JP 2011500808 A JP2011500808 A JP 2011500808A JP 2011515399 A5 JP2011515399 A5 JP 2011515399A5
Authority
JP
Japan
Prior art keywords
cells
composition according
subject
composition
high frequency
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011500808A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011515399A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/001727 external-priority patent/WO2009117116A2/en
Publication of JP2011515399A publication Critical patent/JP2011515399A/ja
Publication of JP2011515399A5 publication Critical patent/JP2011515399A5/ja
Pending legal-status Critical Current

Links

JP2011500808A 2008-03-20 2009-03-19 熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法 Pending JP2011515399A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3831308P 2008-03-20 2008-03-20
US61/038,313 2008-03-20
PCT/US2009/001727 WO2009117116A2 (en) 2008-03-20 2009-03-19 Heat shock protein gp96 vaccination and methods of using same

Publications (2)

Publication Number Publication Date
JP2011515399A JP2011515399A (ja) 2011-05-19
JP2011515399A5 true JP2011515399A5 (enExample) 2012-01-12

Family

ID=41091447

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011500808A Pending JP2011515399A (ja) 2008-03-20 2009-03-19 熱ショックタンパクｇｐ９６ワクチン接種及びそれを用いた方法

Country Status (9)

Country Link
US (1) US8968720B2 (enExample)
EP (1) EP2274001A4 (enExample)
JP (1) JP2011515399A (enExample)
KR (1) KR20110017356A (enExample)
CN (1) CN102036677A (enExample)
AU (1) AU2009226077B2 (enExample)
CA (1) CA2718884C (enExample)
IL (1) IL208241A0 (enExample)
WO (1) WO2009117116A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2285832T3 (es) 1998-02-20 2007-11-16 Univ Miami Complejo de peptido antigenico-proteina de choque termico modificada.
WO2009114085A2 (en) 2008-03-03 2009-09-17 The University Of Miami Allogeneic cancer cell-based immunotherapy
AU2009226077B2 (en) 2008-03-20 2012-04-19 University Of Miami Heat shock protein gp96 vaccination and methods of using same
EP2358383A4 (en) * 2008-11-21 2011-11-23 Univ Miami HIV / SIV VACCINES FOR THE MANUFACTURE OF SLEEPAGE AND SYSTEM IMMUNITY
CN102199204B (zh) * 2011-03-15 2014-03-19 中国科学院微生物研究所 鸡源热休克蛋白及其编码基因和应用
CN103372209B (zh) * 2012-04-24 2014-09-17 中国科学院微生物研究所 gp96蛋白的抗体在制备癌细胞抑制剂中的应用
CN104211772A (zh) * 2013-12-18 2014-12-17 深圳市康尔诺生物技术有限公司 结直肠癌抗原肽与热休克蛋白的复合物及其应用
US10046047B2 (en) * 2015-02-06 2018-08-14 Heat Biologics, Inc. Vector co-expressing vaccine and costimulatory molecules
AU2016271144B2 (en) * 2015-06-01 2018-10-25 Reber Genetics Co., Ltd. Vaccine compositions against porcine reproductive and respiratory syndrome and porcine circovirus associated diseases
US10133916B2 (en) 2016-09-07 2018-11-20 Steven M. Gottlieb Image and identity validation in video chat events
CA3040123A1 (en) 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
WO2018187260A1 (en) 2017-04-04 2018-10-11 Heat Biologics, Inc. Intratumoral vaccination
AU2018373390A1 (en) * 2017-11-27 2020-05-21 Heat Biologics, Inc. Gp96-based cancer therapy
CN108175853A (zh) * 2018-01-24 2018-06-19 上海赛群生物科技有限公司 一种肿瘤细胞疫苗及其制备方法
WO2020076568A1 (en) * 2018-10-10 2020-04-16 University Of Miami Methods and compositions for treating cancer
CN110305874A (zh) * 2019-06-19 2019-10-08 浙江省肿瘤医院 长爪沙鼠免疫球蛋白IgG1、IgG2重组蛋白、基因及其应用

Family Cites Families (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215051A (en) 1979-08-29 1980-07-29 Standard Oil Company (Indiana) Formation, purification and recovery of phthalic anhydride
US5168062A (en) 1985-01-30 1992-12-01 University Of Iowa Research Foundation Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
US4690915A (en) 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
US5217891A (en) 1987-07-28 1993-06-08 Chiron Corporation DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
WO1989012455A1 (en) 1988-06-15 1989-12-28 Whitehead Institute For Biomedical Research Stress proteins and uses therefor
US5137819A (en) 1988-07-08 1992-08-11 University Of British Columbia Cellulose binding fusion proteins for immobilization and purification of polypeptides
WO1990002564A1 (en) 1988-09-12 1990-03-22 Codon Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5108921A (en) 1989-04-03 1992-04-28 Purdue Research Foundation Method for enhanced transmembrane transport of exogenous molecules
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
WO1991002077A1 (en) 1989-07-28 1991-02-21 The United States Of America, Represented By The Secretary, United States Department Of Commerce Efficient directional genetic cloning system
GB9007194D0 (en) 1990-03-30 1990-05-30 Wellcome Found Live vaccines
US5348945A (en) 1990-04-06 1994-09-20 Wake Forest University Method of treatment with hsp70
US5188964A (en) 1990-04-12 1993-02-23 Board Of Regents, The University Of Texas System Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
GB9016315D0 (en) 1990-07-25 1990-09-12 Burnie James P Medicaments
ATE154759T1 (de) 1990-11-08 1997-07-15 Univ London Mycobacterium als adjuvans für antigene
GB9024320D0 (en) 1990-11-08 1990-12-19 Univ London Treatment of uveitis
GB2251186A (en) 1990-12-04 1992-07-01 Randall Neal Gatz Polypeptide for use in treatment of autoimmune disease
NZ241954A (en) 1991-03-15 1994-01-26 Amgen Inc Compositions of g-csf for pulmonary administration.
GB9200949D0 (en) 1992-01-17 1992-03-11 Medical Res Council Diagnostic peptides
FR2688227A1 (fr) 1992-03-04 1993-09-10 Inst Nat Sante Rech Med Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
IT1262896B (it) 1992-03-06 1996-07-22 Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
FI944102A7 (fi) 1992-03-09 1994-09-07 Istituto Naz Per Lo Studio E La Kasvaimen kasvua estämään kykenevä proteiiniyhdiste
EP0636248A4 (en) 1992-04-14 1996-11-13 Univ Duke METHOD FOR DETECTING P53 AND HSP70 COMPLEX CONTAINING TUMORS.
IL102687A (en) 1992-07-30 1997-06-10 Yeda Res & Dev Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
WO1994003599A1 (fr) 1992-08-04 1994-02-17 Sagami Chemical Research Center ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
GB2270076A (en) 1992-08-18 1994-03-02 Univ Manchester Human HSP 90 Epitopes
GB9223816D0 (en) 1992-11-13 1993-01-06 Medical Res Council Heat shock proteins and the treatment of tumours
CN1119459A (zh) 1993-03-19 1996-03-27 柏伦格-英格尔海姆国际股份公司 肿瘤疫苗的制备方法
US5496934A (en) 1993-04-14 1996-03-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Nucleic acids encoding a cellulose binding domain
US5645829A (en) 1993-06-18 1997-07-08 Beth Israel Hospital Association Mesothelial cell gene therapy
WO1995004824A1 (en) 1993-08-05 1995-02-16 Medvet Science Pty. Ltd. Generation of dna libraries and retroviral vectors for same
US5705159A (en) 1993-08-31 1998-01-06 John Wayne Cancer Institute Immunoreactive peptide sequence from a 43 KD human cancer antigen
US5444087A (en) 1993-10-19 1995-08-22 Bristol-Myers Squibb Company Manumycin compounds
US5997873A (en) 1994-01-13 1999-12-07 Mount Sinai School Of Medicine Of The City University Of New York Method of preparation of heat shock protein 70-peptide complexes
US5750119A (en) 1994-01-13 1998-05-12 Mount Sinai School Of Medicine Of The City University Of New York Immunotherapeutic stress protein-peptide complexes against cancer
WO1995022618A1 (en) 1994-02-22 1995-08-24 Dana-Farber Cancer Institute Nucleic acid delivery system, method of synthesis and uses thereof
US5961979A (en) 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
US5451569A (en) 1994-04-19 1995-09-19 Hong Kong University Of Science And Technology R & D Corporation Limited Pulmonary drug delivery system
EP0769932B1 (en) 1994-07-08 1998-10-14 Baxter International Inc. Implanted device containing tumor cells for the treatment of cancer
US5772995A (en) 1994-07-18 1998-06-30 Sidney Kimmel Cancer Center Compositions and methods for enhanced tumor cell immunity in vivo
EP0784483B1 (en) 1994-10-03 2000-11-29 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule
US5703057A (en) 1995-04-07 1997-12-30 Board Of Regents The University Of Texas System Expression library immunization
AU712907B2 (en) 1995-08-18 1999-11-18 Sloan-Kettering Institute For Cancer Research Method for treatment of cancer and infectious diseases and compositions useful in same
US6761892B1 (en) 1995-08-18 2004-07-13 Sloan-Kettering Institute For Cancer Research Heat shock protein-based vaccines and immunotherapies
US6331299B1 (en) 1995-08-18 2001-12-18 Sloan-Kettering Institute For Cancer Research Method for treatment of cancer and infectious disease and compositions useful in same
US6719974B1 (en) 1995-08-18 2004-04-13 Sloan-Kettering Institute For Cancer Research Heat shock protein-based vaccines and immunotherapies
US5985270A (en) 1995-09-13 1999-11-16 Fordham University Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
US5935576A (en) 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
EP0851765A4 (en) 1995-09-13 2000-01-19 Univ Fordham THERAPEUTIC AND PROPHYLACTIC PROCESSES THAT USE HEAT SHOCK PROTEINS
US5837251A (en) 1995-09-13 1998-11-17 Fordham University Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
WO1997026910A2 (de) 1996-01-27 1997-07-31 Max-Delbrück-Centrum für Molekulare Medizin Tumorimpfstoff für die immuntherapie von malignen tumoren
JP2000516911A (ja) 1996-03-28 2000-12-19 ホワイトヘッド インスティテュート フォー バイオメディカル リサーチ オプソニン強化細胞、および抗原に対する免疫応答を調節する方法
US5747332A (en) 1996-09-20 1998-05-05 University Of New Mexico Methods for purifying and synthesizing heat shock protein complexes
US6130087A (en) 1996-10-07 2000-10-10 Fordham University Methods for generating cytotoxic T cells in vitro
AU736318B2 (en) 1996-11-26 2001-07-26 Nventa Biopharmaceuticals Corporation Immune responses using compositions containing stress proteins
US5830464A (en) 1997-02-07 1998-11-03 Fordham University Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
US6017540A (en) 1997-02-07 2000-01-25 Fordham University Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
US6007821A (en) 1997-10-16 1999-12-28 Fordham University Method and compositions for the treatment of autoimmune disease using heat shock proteins
US5948646A (en) 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
ES2285832T3 (es) 1998-02-20 2007-11-16 Univ Miami Complejo de peptido antigenico-proteina de choque termico modificada.
US6451316B1 (en) 1998-10-05 2002-09-17 University Of Conneticut Health Center Methods for generating antigen-reactive T cells in vitro
US6797480B1 (en) 1998-10-05 2004-09-28 University Of Connecticut Health Center Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
US6475490B1 (en) 1998-10-19 2002-11-05 Fordham University Compositions and methods for promoting tissue repair using heat shock proteins
US6317435B1 (en) 1999-03-08 2001-11-13 Qualcomm Incorporated Method and apparatus for maximizing the use of available capacity in a communication system
EP1194167B1 (en) 1999-06-09 2009-08-19 Immunomedics, Inc. Immunotherapy of autoimmune disorders using antibodies which target b-cells
US6651655B1 (en) 2000-01-18 2003-11-25 Quadrant Technologies Limited Inhaled vaccines
WO2001078655A2 (en) 2000-04-17 2001-10-25 Alan Houghton Methods and compositions for heat shock protein mediated immunotherapy of melanoma
BR0111956A (pt) 2000-06-26 2003-05-13 Stressgen Biotechnologies Corp Tratamento do vìrus do papiloma humano
DK1363938T3 (en) 2000-08-03 2014-03-24 Univ Johns Hopkins Molecular vaccine that connects an endoplasmic reticulum-chaperonepolypeptid with an antigen
US7132109B1 (en) 2000-10-20 2006-11-07 University Of Connecticut Health Center Using heat shock proteins to increase immune response
US20030044386A1 (en) 2001-07-11 2003-03-06 Barber Glen N. Recombinant VSV for the treatment of tumor cells
WO2003053338A2 (en) 2001-11-16 2003-07-03 The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services Novel chimeric rev, tat, and nef antigens
EP1539197A4 (en) 2002-02-01 2006-08-02 Univ Jefferson TREATMENT OF TUMOR CELLS FOR USE IN IMMUNOTHERAPY IN CANCER
CA2501744C (en) 2002-10-09 2012-01-03 Central Iowa Health System Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
ATE448312T1 (de) * 2003-09-26 2009-11-15 Merck Serono Sa Leitsequenzen zur verwendung bei der produktion von proteinen
CA2540283C (en) * 2003-09-26 2019-05-21 University Of Miami Tumor vaccine
FR2867982B1 (fr) 2004-03-26 2007-07-20 Jean Marie Andrieu Procede pour amplifier l'activite de vaccins therapeutiques
WO2005113003A2 (en) 2004-04-16 2005-12-01 Genentech, Inc. Method for augmenting b cell depletion
WO2005120558A2 (en) 2004-05-25 2005-12-22 University Of Connecticut Health Center Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
CN100467063C (zh) * 2004-07-07 2009-03-11 中国科学院微生物研究所 一类免疫佐剂及其在抗病毒疫苗或药物制备中的应用
JP5122983B2 (ja) 2005-02-24 2013-01-16 メディカル リサーチ カウンシル Ｈｉｖｃｏｎ：ｈｉｖ免疫原及びその使用
CN101057975B (zh) 2006-12-13 2012-10-10 中国科学院微生物研究所 一种抗免疫耐受性和免疫缺陷性病毒的鸡尾酒疫苗及其应用
WO2009114085A2 (en) 2008-03-03 2009-09-17 The University Of Miami Allogeneic cancer cell-based immunotherapy
AU2009226077B2 (en) 2008-03-20 2012-04-19 University Of Miami Heat shock protein gp96 vaccination and methods of using same
IL190438A0 (en) 2008-03-25 2008-12-29 K M B Y Ltd A method of setting a drill for drilling a hole in a bone coaxial to the hole in the nail and aiming device for realizing this method
PT2260145E (pt) 2008-03-26 2012-09-18 Clariant Finance Bvi Ltd Composições de branqueamento ótico melhoradas
KR101612275B1 (ko) 2008-04-02 2016-04-14 사노피 악티노마두라 나미비엔시스로부터 유래된 고도로 브릿징된 펩타이드
EP2358383A4 (en) 2008-11-21 2011-11-23 Univ Miami HIV / SIV VACCINES FOR THE MANUFACTURE OF SLEEPAGE AND SYSTEM IMMUNITY
EP2387415A1 (en) 2009-01-16 2011-11-23 AGIRx Limited Vaccine compositions
KR20130113953A (ko) 2010-05-21 2013-10-16 유니버시티 오브 마이애미 암 치료
EP2678031A4 (en) 2011-02-23 2015-09-02 Univ Miami COMBINED VACCINATION WITH CELL-BASED GP96-IG-SIV / HIV AND THE RECOMBINANT PROTEIN GP120 FOR PROTECTION AGAINST SIV / HIV

Similar Documents

Publication Publication Date Title
JP2011515399A5 (enExample)
Fernandez-Francos et al. Mesenchymal stem cells as a cornerstone in a galaxy of intercellular signals: basis for a new era of medicine
Mao et al. Type IV collagens and basement membrane diseases: cell biology and pathogenic mechanisms
WO2014186469A3 (en) Human application of engineered chimeric antigen receptor (car) t-cells
SA518400424B1 (ar) جزيئات الجسم المضاد لعلاج السرطان
IL268925B (en) Devices, methods, and compositions useful in cryo-preservation, -storage, -transport, and application of therapeutic mammalian cells
PH12021551189A1 (en) Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
MX375838B (es) Agente reductor de amoniaco para usarse en el tratamiento de enfermedades asociadas con activación de células estrelladas hepáticas.
EP3471735A4 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF CANCER AND AUTOIMMUNE DISEASES
MX2015017961A (es) Compuestos orgánicos pirrolo-pirrol carbamato y relacionados, composiciones farmacéuticas y usos médicos de los mismos.
WO2015048345A3 (en) Compositions and formulations for prevention and reduction of tumorigenesis, cancer cell proliferation and invasion, and methods of production and use thereof in cancer treatment
JP2011513399A5 (enExample)
TN2012000335A1 (en) Antibody formulation and therapeutic regimens
CL2015003199A1 (es) Peptidos terapeuticos
UA109464C2 (uk) Спірооксіндольні антагоністи mdm2
WO2017044894A3 (en) Cartilage-homing peptides
BR112013010834B1 (pt) polipeptídeos de fator ix modificados e usos dos mesmos
EA201171279A1 (ru) Производство инкапсулированных наночастиц с высокой объемной долей
CL2016002088A1 (es) Anticuerpos monoclonales biespecificos contra il-13/il-17; ácido nucleico; célula huésped; método de producción del anticuerpo; inmunoconjugados; formulación farmacéutica; y usos de los anticuerpos biespecíficios para el tratamiento del asma moderada a severa y/o asma eosinofílica.
MX2017014716A (es) Polipeptido de fusion anti-cancer.
WO2015184375A3 (en) Compositions and methods for promoting intestinal stem cell and/or non-stem progenitor cell function
BR112013033544A2 (pt) dosagem e administração de anticorpos anti-erbb3 em combinação com paclitaxel para tratamento de cânceres ginecológicos
UY33219A (es) Cetoenoles cíclicos para terapias
BR112014031798A2 (pt) compostos de heteroaril e métodos de uso destes
Shaker et al. Photo-irradiation paradigm: mapping a remarkable facile technique used for advanced drug, gene and cell delivery